Quincy Bioscience announces launch of MS HOPE trial
Posted: Wed Jun 09, 2010 1:40 am
HOPE Trials and Quincy Bioscience together with MS advocate and author Shelley Peterman Schwarz officially announce the launch of an innovative Multiple Sclerosis study evaluating the effect of a jellyfish protein on quality of life symptoms for people diagnosed with multiple sclerosis.
MS HOPE Trials is enrolling participants with all forms of multiple sclerosis at the HOPE Trials website. By utilizing the internet for both recruitment and data gathering, Quincy Bioscience will reach a large number of people who might otherwise not participate in research due to time and travel limitations.
The MS HOPE Trial is one study of several planned under HOPE Trials, a larger research initiative by Quincy Bioscience, a Madison Wisconsin based biotechnology company which has developed the use of a jellyfish protein called apoaequorin for a wide range of potential health benefits... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1848